Paul M Epstein Selected Research

Colforsin

7/2015

Inhibition of breast cancer cell migration by activation of cAMP signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul M Epstein Research Topics

Disease

3	Inflammation (Inflammations) 01/2022 - 12/2017
3	Neoplasms (Cancer) 01/2013 - 02/2005
2	Psoriatic Arthritis 01/2022 - 01/2021
2	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 07/2015 - 01/2013
1	Fibrosarcoma 01/2021
1	Leukemia 12/2017
1	Multiple Myeloma 01/2015
1	Glucocorticoid Receptor Deficiency 02/2010
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2005

Drug/Important Bio-Agent (IBA)

5	diethylstilbestrol monophosphate (PDES)IBA 01/2022 - 01/2006
4	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2022 - 01/2006
4	Cyclic NucleotidesIBA 01/2022 - 01/2006
3	Phosphodiesterase 4 InhibitorsIBA 01/2022 - 02/2005
3	GlucocorticoidsIBA 01/2015 - 02/2005
2	Phosphotransferases (Kinase)IBA 01/2021 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 01/2013
1	AntigensIBA 01/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	ColforsinIBA 07/2015
1	Dipyridamole (Persantine)FDA LinkGeneric 07/2015
1	Messenger RNA (mRNA)IBA 07/2015
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	Type 6 Cyclic Nucleotide PhosphodiesterasesIBA 01/2013
1	CryptochromesIBA 01/2013
1	CarcinogensIBA 01/2013
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 02/2005
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 02/2005
1	3',5'-Cyclic-AMP Phosphodiesterases (3',5' Cyclic Nucleotide Phosphodiesterase)IBA 02/2005

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021